Risk of Second Primary Cancers After Early Breast Cancer Maurie Markman, MD April 24, 2026

https://www.medscape.com/viewarticle/risk-second-primary-cancers-after-early-breast-cancer-2026a1000c88

European Association of Dermato-Oncology (EADO) Congress 2026

https://www.medscape.com/c25/p14/european-association-dermato-oncology-eado-congress-2026-2026a1000ale 11th World Congress of Melanoma (WCM) and 21st EADO Congress 2025 https://www.medscape.com/viewcollection/37751

ICIs Show Favorable Responses in Mediastinal B-Cell Lymphoma Nancy A. Melville April 24, 2026

https://www.medscape.com/viewarticle/icis-show-favorable-responses-mediastinal-b-cell-lymphoma-2026a1000d32

Pancreatic Cancer Vaccine Still Shows Promise 6 Years Out Sharon Worcester April 24, 2026

https://www.medscape.com/viewarticle/pancreatic-cancer-vaccine-still-shows-promise-6-years-out-2026a1000d2b

EMA Recommends Generic for Advanced/Metastatic Breast Cancer Sophie Cousins Medscape Europe April 24, 2026

https://www.medscape.com/viewarticle/ema-recommends-generic-advanced-metastatic-breast-cancer-2026a1000d3v

EMA Says No to Drug for PD-L1-High Melanoma Dr Rob Hicks MBBS DRCOG MRCGP Medscape Europe DISCLOSURES April 24, 2026

https://www.medscape.com/viewarticle/ema-says-no-drug-pd-l1-high-melanoma-2026a1000d4z

Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in male rodents

Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in male rodents Christian E. Edvardssona ∙ Xinming Zhangb,c ∙ Thaynnam A. Emousa,d ∙ Louise Adermarka,e ∙ Sarah Witleya ∙ Mia Ericsone ∙ et al. https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(26)00101-5/fulltext?dgcid=hubspot_update_feature_updatealerts_ebiom&utm_campaign=update-ebiom&utm_medium=email&_hsenc=p2ANqtz--Zh0sGt0Ic-AuRNyTeKt-OauAOMjeBSaZg3W-ySCJMLHUFUiPUWdv7oC4Yod9rFc8JoUTIILs3P7dM40lCpxkBZ_3AMg&_hsmi=415197735&utm_content=414889854&utm_source=hs_email